For example, Li et al.’s optimized polypeptide neoantigen DNA vaccine induced strong neoantigen-specific T-cell responses in preclinical mouse breast cancer models E0771 and 4T1 and combined with anti-PD-L1 antibody effectively inhibited the growth of E0771 tumors and maintained anti-tumor immunity [359]. The gene discussed is CD274; the disease is neoplasm.